Acurx Pharmaceuticals, Inc. (ACXP) vs Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)

A side-by-side comparison of Acurx Pharmaceuticals, Inc. and Cuprina Holdings (Cayman) Limited Class A Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Acurx Pharmaceuticals, Inc. logo
ACXP
Acurx Pharmaceuticals, Inc.
$6M
$1.31HealthcareDelayed quote: Oct 6, 2026, 9:58 AM EDT
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares logo
CUPR
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
$6M
$2.20HealthcareDelayed quote: Oct 6, 2026, 9:53 AM EDT

Total return — ACXP vs CUPR

growth of $100 · dividends reinvested · last 1y
ACXP -80.5% (-80.5%/yr)CUPR -93.2% (-93.2%/yr)ACXP compounded faster over this window
050100150200250Start $1002026$20$7
ACXP CUPR

ACXP vs CUPR: by the numbers

  • •CUPR is the larger company ($6M vs $6M market cap).
  • •Both run net losses; ACXP's is the smaller (0.00% vs -9366.75% net margin).

Metrics side by side

Valuation

MetricACXPCUPR
P/B ratio0.691.50

Profitability

MetricACXPCUPR
Gross margin0.00%-1.29%
Operating margin0.00%-9154.62%
Net margin0.00%-9366.75%
ROE-92.08%-92.44%
ROIC-94.08%-84.15%

Growth (annualized)

MetricACXPCUPR
Total return CAGR (5Y)-57.41%N/A

Go deeper

Full ACXP analysisFull CUPR analysisInteractive comparison tool

Dig into the metrics

Acurx Pharmaceuticals ROECuprina Holdings (Cayman) Limited Class A Ordinary Shares ROEAcurx Pharmaceuticals operating marginCuprina Holdings (Cayman) Limited Class A Ordinary Shares operating marginAcurx Pharmaceuticals revenue growthCuprina Holdings (Cayman) Limited Class A Ordinary Shares revenue growthAcurx Pharmaceuticals free cash flowCuprina Holdings (Cayman) Limited Class A Ordinary Shares free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.